|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-5-27
|
|
pubmed:abstractText |
Coinfection with hepatitis C virus (HCV) and HIV is not uncommon and therapies for both infections are currently available. A major drawback, however, could be a potentially higher risk for mitochondrial toxicity (MT), defined as the elevation of pancreatic enzymes or lactate levels due to the nucleoside analogue reverse transcriptase inhibitors contained in both therapies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1359-6535
|
|
pubmed:author |
pubmed-author:BigliaAlejandraA,
pubmed-author:BlancoJose LuisJL,
pubmed-author:GarcíaFelipeF,
pubmed-author:GarcíaMercedesM,
pubmed-author:GatellJose MariaJM,
pubmed-author:LagunoMontseM,
pubmed-author:LarrousseMariaM,
pubmed-author:LeonAgatheA,
pubmed-author:LoncáMontseM,
pubmed-author:MallolasJosepJ,
pubmed-author:MartínezEstebanE,
pubmed-author:MilinkovicAnaA,
pubmed-author:MiróJose MariaJM,
pubmed-author:MurillasJavierJ,
pubmed-author:de LazzariElisaE
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
423-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15918333-Adult,
pubmed-meshheading:15918333-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15918333-Antiviral Agents,
pubmed-meshheading:15918333-Drug Administration Schedule,
pubmed-meshheading:15918333-Drug Therapy, Combination,
pubmed-meshheading:15918333-Female,
pubmed-meshheading:15918333-HIV Infections,
pubmed-meshheading:15918333-Hepatitis C,
pubmed-meshheading:15918333-Humans,
pubmed-meshheading:15918333-Interferon-alpha,
pubmed-meshheading:15918333-Male,
pubmed-meshheading:15918333-Mitochondrial Diseases,
pubmed-meshheading:15918333-Prospective Studies,
pubmed-meshheading:15918333-Recombinant Proteins,
pubmed-meshheading:15918333-Ribavirin,
pubmed-meshheading:15918333-Risk Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients.
|
|
pubmed:affiliation |
Infectious Diseases Unit, Hospital Clinic Barcelona, Barcelona, Spain. mlaguno@clinic.ub.es
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
